Amalgamated Bank Has $11.91 Million Stake in Aflac Incorporated (NYSE:AFL)

Amalgamated Bank cut its holdings in Aflac Incorporated (NYSE:AFL) by 8.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 144,413 shares of the financial services provider’s stock after selling 13,336 shares during the period. Amalgamated Bank’s holdings in Aflac were worth $11,914,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Flputnam Investment Management Co. lifted its stake in Aflac by 0.5% in the fourth quarter. Flputnam Investment Management Co. now owns 25,031 shares of the financial services provider’s stock valued at $2,065,000 after buying an additional 122 shares during the period. Baystate Wealth Management LLC increased its stake in Aflac by 24.1% in the third quarter. Baystate Wealth Management LLC now owns 675 shares of the financial services provider’s stock valued at $52,000 after purchasing an additional 131 shares in the last quarter. Brighton Jones LLC raised its holdings in Aflac by 2.3% in the third quarter. Brighton Jones LLC now owns 6,156 shares of the financial services provider’s stock worth $472,000 after purchasing an additional 136 shares during the period. MV Capital Management Inc. boosted its position in shares of Aflac by 3.7% during the third quarter. MV Capital Management Inc. now owns 3,779 shares of the financial services provider’s stock worth $290,000 after purchasing an additional 136 shares in the last quarter. Finally, Simon Quick Advisors LLC boosted its position in shares of Aflac by 4.9% during the fourth quarter. Simon Quick Advisors LLC now owns 2,950 shares of the financial services provider’s stock worth $243,000 after purchasing an additional 139 shares in the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently commented on AFL shares. Truist Financial raised their price objective on Aflac from $80.00 to $82.00 and gave the stock a “hold” rating in a research note on Friday. Piper Sandler lifted their price objective on Aflac from $90.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, April 5th. StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a research note on Friday. Wells Fargo & Company dropped their target price on shares of Aflac from $83.00 to $81.00 and set an “equal weight” rating on the stock in a report on Thursday, April 11th. Finally, Morgan Stanley upped their price target on shares of Aflac from $80.00 to $84.00 and gave the company an “equal weight” rating in a report on Monday, April 15th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat, Aflac has an average rating of “Hold” and an average target price of $82.31.

Aflac Trading Down 1.0 %

NYSE AFL traded down $0.83 on Friday, reaching $83.21. The company had a trading volume of 2,938,536 shares, compared to its average volume of 2,533,085. The firm has a market cap of $47.88 billion, a price-to-earnings ratio of 9.18, a P/E/G ratio of 2.31 and a beta of 0.91. Aflac Incorporated has a fifty-two week low of $64.10 and a fifty-two week high of $86.26. The business has a 50 day moving average of $83.08 and a two-hundred day moving average of $81.87. The company has a debt-to-equity ratio of 0.34, a current ratio of 0.08 and a quick ratio of 0.06.

Aflac (NYSE:AFL) last issued its quarterly earnings results on Wednesday, May 1st. The financial services provider reported $1.66 EPS for the quarter, beating analysts’ consensus estimates of $1.58 by $0.08. The business had revenue of $5.44 billion for the quarter, compared to analysts’ expectations of $4.09 billion. Aflac had a net margin of 27.67% and a return on equity of 16.88%. The business’s quarterly revenue was up 13.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.55 earnings per share. Analysts forecast that Aflac Incorporated will post 6.41 EPS for the current year.

Aflac Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 3rd. Investors of record on Wednesday, May 22nd will be issued a $0.50 dividend. This is a boost from Aflac’s previous quarterly dividend of $0.42. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.40%. The ex-dividend date of this dividend is Tuesday, May 21st. Aflac’s dividend payout ratio (DPR) is currently 22.08%.

Insider Buying and Selling at Aflac

In related news, SVP Albert Riggieri sold 8,000 shares of the firm’s stock in a transaction dated Thursday, March 14th. The shares were sold at an average price of $83.34, for a total value of $666,720.00. Following the transaction, the senior vice president now owns 32,825 shares of the company’s stock, valued at approximately $2,735,635.50. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, SVP Albert Riggieri sold 8,000 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $83.34, for a total value of $666,720.00. Following the transaction, the senior vice president now owns 32,825 shares in the company, valued at approximately $2,735,635.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Thomas J. Kenny sold 5,000 shares of Aflac stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total value of $423,100.00. Following the sale, the director now owns 17,920 shares in the company, valued at $1,516,390.40. The disclosure for this sale can be found here. In the last 90 days, insiders sold 46,493 shares of company stock worth $3,765,706. 0.90% of the stock is owned by corporate insiders.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.